Unusual structural features of the bacteriophage-associated hyaluronate lyase (hylp2)

The Journal of Biological Chemistry
Parul MishraVinod Bhakuni


Hyaluronate lyases are a class of endoglycosaminidase enzymes, which are of considerable complexity and heterogeneity. Their primary function is to degrade hyaluronan and certain other glycosaminoglycans and facilitate the spread of disease. Among hyaluronate lyases, the bacteriophage-associated enzymes are unique as they have the lowest molecular mass, very low amino acid sequence homology with bacterial hyaluronate lyases, and exhibit absolute specificity for one type of glycosaminoglycan, i.e. hyaluronan. Despite such unique characteristics significant details on structural features of these lyases are not available. The Streptococcus pyogenes bacteriophage 10403 contains a gene, hylP2, which encodes for hyaluronate lyase (HylP2) in this organism. HylP2 was cloned, overexpressed, and purified to homogeneity. The recombinant HylP2 exists as a homotrimer of molecular mass about 110 kDa, under physiological conditions. Limited proteolysis and guanidine hydrochloride denaturation studies demonstrated that the N-terminal region of the protein is flexible, whereas the C-terminal portion has a compact conformation. The enzyme shows sequential unfolding, with the N-terminal unfolding first followed by the simultaneous unfolding and ...Continue Reading


Apr 1, 1986·Applied Biochemistry and Biotechnology·R J LinhardtC L Cooney
Mar 18, 1970·Biochimica Et Biophysica Acta·T Ohya, Y Kaneko
Aug 1, 1980·Journal of Biochemistry·T YoshidaG Kikuchi
Sep 1, 1995·Protein Science : a Publication of the Protein Society·G Kreil
Apr 16, 1998·Biochimica Et Biophysica Acta·S J Hubbard
Feb 17, 2000·FEMS Microbiology Letters·W L Hynes, S L Walton
Feb 26, 2000·FEMS Microbiology Letters·W L HynesL J Aridgides
Apr 11, 2001·Proceedings of the National Academy of Sciences of the United States of America·J J FerrettiR McLaughlin
Aug 31, 2001·The Journal of Biological Chemistry·S Li, M J Jedrzejas
Mar 28, 2002·Proceedings of the National Academy of Sciences of the United States of America·James C SmootJames M Musser
Apr 5, 2002·Microbes and Infection·Dean J HarringtonNeil Chanter
Jun 20, 2002·The Biochemical Journal·John R BakerDavid G Pritchard
Jul 18, 2002·Proceedings of the National Academy of Sciences of the United States of America·Stephen B BeresJames M Musser
Aug 13, 2003·The Journal of Biological Chemistry·Sarita Chaturvedi, Vinod Bhakuni
Feb 24, 2004·Frontiers in Bioscience : a Journal and Virtual Library·George Yen-Hsi Liu, Victor Nizet
Nov 30, 2005·Proceedings of the National Academy of Sciences of the United States of America·Nicola L SmithGary W Black
Dec 22, 2005·Infection and Immunity·Clarise Rivera Starr, N Cary Engleberg


Jun 1, 2013·Acta Crystallographica. Section F, Structural Biology and Crystallization Communications·Abdul Hamid KhanNasrullah Bangulzai
Jan 12, 2013·Current Protein & Peptide Science·Zuzanna Drulis-KawaRob Lavigne
Mar 25, 2017·Applied Microbiology and Biotechnology·Agnieszka LatkaZuzanna Drulis-Kawa
Oct 14, 2008·The Journal of Biological Chemistry·Parul Mishra, Vinod Bhakuni

Related Concepts

Percutaneous Coronary Intervention for ST Elevation Myocardial Infarction-Unstable-Over 12 Hours From Symptom Onset
Circular Dichroism, Vibrational
Cross-Linking Reagents
Dose-Response Relationship, Drug
Alkalescens-Dispar Group

Related Feeds

Biosynthetic Transformations

Biosyntheic transformtions are multi-step, enzyme-catalyzed processes where substrates are converted into more complex products in living organisms. Simple compounds are modified, converted into other compounds, or joined together to form macromolecules. Discover the latest research on biosynthetic transformations here.

ASBMB Publications

The American Society for Biochemistry and Molecular Biology (ASBMB) includes the Journal of Biological Chemistry, Molecular & Cellular Proteomics, and the Journal of Lipid Research. Discover the latest research from ASBMB here.

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.